• Home

Internet Book of Critical Care (IBCC)

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • ToC
  • About the IBCC
  • Tweet Us
  • RSS
  • IBCC Podcast
You are here: Home / IBCC / Hyperphosphatemia


Hyperphosphatemia

April 1, 2023 by Josh Farkas

CONTENTS

  • Rapid Reference 🚀
  • Symptoms
  • Phosphate level
  • Causes of hyperphosphatemia
  • Treatment
  • Podcast
  • Questions & Discussions
  • Pitfalls

rapid reference

(back to contents)



symptoms

(back to contents)


Hyperphosphatemia itself is generally asymptomatic.  However, hyperphosphatemia may indirectly cause symptoms in two ways.

more common: symptomatic hypocalcemia

  • Phosphate binds calcium, which can lead to hypocalcemia.
  • Hypocalcemia may cause symptoms, for example:
    • Paresthesias (tingling around mouth, hands).
    • Muscle cramping, weakness, laryngospasm.
    • Anxiety, confusion, seizure.
    • Hypotension, ventricular arrhythmias.
  • More on clinical findings in hypocalcemia: 📖

rare: calciphylaxis

  • Elevation of phosphate may promote calciphylaxis (the precipitation of calcium phosphate in tissues).
  • This may manifest with necrotizing skin ulceration:


phosphate level

(back to contents)


phosphate level

  • 2.5-5 mg/dL = normal phosphate.
  • Pseudohyperphosphatemia (false elevation) may result from:
    • Hyperlipidemia.
    • Hyperbilirubinemia.
    • Hyperglobulinemia (e.g. multiple myeloma).
    • Hemolyzed specimen.
    • Liposomal amphotericin B.

calcium-phosphate product

  • More important than the phosphate level alone, as this predicts the risk of calciphylaxis (precipitation of calcium phosphate in tissues).
  • Defined as calcium level multiplied by phosphate level (with both measured in mg/dL).
  • Calcium-phosphate product above 70 mg*mg/dL*dL causes a risk of calciphylaxis.

causes of hyperphosphatemia

(back to contents)


Renal Failure Plus…

  • Normally the kidneys are highly efficient at phosphate excretion. Sustained hyperphosphatemia generally won't occur without renal failure (GFR <25 ml/min).
  • However, there is also generally an inciting cause as well:

…tissue necrosis

  • Tumor lysis syndrome.
  • Rhabdomyolysis.
  • Hemolysis.
  • Fulminant hepatitis.
  • Severe hyperthermia.

…endocrinopathy

  • Hypoparathyroidism.
  • Hypothyroidism or hyperthyroidism.
  • Adrenal insufficiency.

…medications

  • Exogenous phosphate intake (e.g. phosphate-containing laxatives/enemas, TPN).
  • Vitamin D toxicity.
  • Bisphosphonates.
  • Fosphenytoin.

treatment

(back to contents)


acute treatment

  • Reverse underlying problem.
  • Phosphate-restricted diet.
  • Volume resuscitation, followed by forced diuresis using acetazolamide +/- loop diuretic.
  • Hemodialysis may be required in severe renal dysfunction (especially in tumor lysis syndrome).

chronic treatment: phos-restricted diet plus phosphate binder

  • Calcium acetate (Phoslo™️) 💊
    • 667 mg tablets, start with two tablets TID with meals
    • Can be useful in patients with hypocalcemia.
    • ⚠️ Avoid in hypercalcemia, vitamin D intoxication, Ca-Phos product > 66.
  • Sevelamer (Renagel™️) 💊
    • Start at 800 mg PO TID with meals, double dose if needed.
    • Nonabsorbable resin avoids problems with Mg, Ca (may be preferable for patients on dialysis).
    • ⚠️ May adsorb some drugs.

podcast

(back to contents)


Please note: The segment on hyperphosphatemia starts at 14:44.

Follow us on iTunes

The Podcast Episode

http://traffic.libsyn.com/ibccpodcast/IBCC_EP_36_-_All_things_phosphate.mp3

Want to Download the Episode?
Right Click Here and Choose Save-As


questions & discussion

(back to contents)


To keep this page small and fast, questions & discussion about this post can be found on another page here.

  • Patients with hyperphosphatemia may have low calcium levels. There may therefore be a temptation to give intravenous calcium to restore the calcium level. However, this would be dangerous because it could increase the calcium-phosphate product, thereby causing calciphylaxis

Guide to emoji hyperlinks 🔗

  • 🧮 = Link to online calculator.
  • 💊 = Link to Medscape monograph about a drug.
  • 💉 = Link to IBCC section about a drug.
  • 📖 = Link to IBCC section covering that topic.
  • 🌊 = Link to FOAMed site with related information.
  • 🎥 = Link to supplemental media.

Cite this post as:

Josh Farkas. Hyperphosphatemia. EMCrit Blog. Published on April 1, 2023. Accessed on December 7th 2025. Available at [https://cmefix.emcrit.org/ibcc/hyperphos/ ].

Financial Disclosures:

The course director, Dr. Scott D. Weingart MD FCCM, reports no relevant financial relationships with ineligible companies. This episode’s speaker(s) report no relevant financial relationships with ineligible companies unless listed above.

CME Review

Original Release: April 1, 2023
Date of Most Recent Review: Jul 1, 2024
Termination Date: Jul 1, 2027

You finished the 'cast,
Now Join EMCrit!

As a member, you can...

  • Get CME hours
  • Get the On Deeper Reflection Podcast
  • Support the show
  • Write it off on your taxes or get reimbursed by your department

Join Now!

The Internet Book of Critical Care is an online textbook written by Josh Farkas (@PulmCrit), an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.


.

Get the EMCrit Newsletter

If you enjoyed this post, you will almost certainly enjoy our others. Subscribe to our email list to keep informed on all of the Resuscitation and Critical Care goodness.

This Post was by the EMCrit Crew, published 3 years ago. We never spam; we hate spammers! Spammers probably work for the Joint Commission.

Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

Resus Leadership Academy

Subscribe by Email

EMCrit is a trademark of Metasin LLC. Copyright 2009-. This site represents our opinions only. See our full disclaimer, our privacy policy, commenting policy and here for credits and attribution.